600566 济川药业
2024/09 - 九个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额1,739,5133,463,9592,620,8331,894,3291,781,691
投资活动产生之现金流量净额(2,076,598)(394,228)(1,503,306)(673,298)(1,481,147)
筹资活动产生之现金流量净额(877,835)(150,689)(117,582)(361,192)373,798
汇率变动对现金及现金等价物的影响----------
现金及现金等价物净增加/(减少)(1,214,919)2,919,042999,945859,840674,341
期初现金及现金等价物余额7,737,9834,818,9413,818,9962,959,1572,284,815
期末现金及现金等价物余额6,523,0637,737,9834,818,9413,818,9962,959,157